Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
71.75
+0.37 (0.52%)
At close: Sep 1, 2026, 4:00 PM EDT
72.20
+0.45 (0.63%)
After-hours: Sep 1, 2026, 4:31 PM EDT

Nektar Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
54.5955.2398.4390.1292.06101.91
Revenue Growth
-27.15%-43.89%9.21%-2.10%-9.67%-33.36%
Gross Profit
54.5955.2367.7456.3570.4277.01
Operating Income
-130.64-130.77-129.92-135.23-240.24-446.1
Net Income
-157.13-164.08-118.96-276.06-368.2-523.84
Earnings Per Share
-6.47-9.73-8.68-21.79-29.55-42.90
EPS Growth
------

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
-1.3811.489.8410.11
Rest of World
55.2397.0578.6482.2191.79
Total
55.2398.4390.1292.06101.91

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
684.34245.75269.1329.44504.98798.78
Total Debt
135.93148.91194.34230.4286.87338.6
Net Cash (Debt)
548.4196.8474.7699.04218.1460.18
Net Cash Growth
-29.55%-24.52%-54.59%-52.61%-45.73%
Net Cash Per Share
22.575.745.457.8217.4837.66

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-233.79-208.51-175.71-192.61-304.01-412.66
Capital Expenditures
-0.94-0.87-1.47-0.87-5.68-14.99
Free Cash Flow
-234.73-209.38-177.18-193.47-309.68-427.65
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%68.82%62.53%76.50%75.57%
Operating Margin
-239.32%-236.77%-131.99%-150.05%-260.97%-437.76%
Pretax Margin
-287.72%-297.32%-121.10%-306.54%-396.48%-513.49%
Profit Margin
-287.84%-297.07%-120.86%-306.31%-399.98%-514.03%
FCF Margin
-429.99%-379.09%-180.01%-214.68%-336.41%-419.65%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-15.8815.8815.8815.8815.88
PS Ratio
45.1715.571.741.204.6124.47